AbCellera Biologics ABCL
$9.69 −$0.78 (-7.45%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $9.73 +0.41%
Open$10.14
Prev close$10.47
Day range$9.58 – $10.26
Volume4.25M
Market cap$3.16B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$10.64M+18.8% YoY
Operating profit-$49.68M+32.5% YoY
Net profit-$40.76M+28.6% YoY
Diluted EPS-$0.13+31.6% YoY
Free cash flow$25.30M+141.1% YoY
Operating cash flow$26.91M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Operating margin-275.7%
Net margin-218.6%
Return on equity-14.6%
Return on assets-10.4%
Return on invested capital-14.3%
Current ratio12.43
Liabilities / assets29.2%
Cash & investments$764.42M
Total debt$128.13M
Net cash (debt)$636.29M
Where the revenue comes from
Quarter 2025/FY
By region
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $10.64M | $4.05M | $8.32M | $75.13M | $44.85M |
| Total Operating Revenue | $10.64M | $4.05M | $8.32M | $75.13M | $44.85M |
| Operating Expense | $60.32M | $62.97M | $61.50M | $278.34M | $70.12M |
| Selling and Admin Expenses | $13.61M | $13.85M | $12.33M | $83.23M | $17.22M |
| Research & Development | $43.54M | $45.99M | $46.66M | $186.83M | $50.09M |
| Depreciation & Amortization & Depletion | $6.81M | $6.99M | $6.84M | $22.17M | $6.12M |
| -Depreciation & Amortization | $6.81M | $6.99M | $6.84M | $22.17M | $6.12M |
| Other Operating Expenses | -$3.64M | -$3.85M | -$4.34M | -$13.89M | -$3.32M |
| Operating Profit | -$49.68M | -$58.92M | -$53.18M | -$203.21M | -$25.27M |
| Net Non-Operating Interest Income (Expense) | $6.87M | -$42,000.00 | $3.64M | $28.33M | $8.48M |
| Non-Operating Interest Income | $6.87M | – | $3.64M | $28.33M | $8.48M |
| Pretax Profit | -$42.81M | -$58.97M | -$49.54M | -$177.60M | -$19.50M |
| Tax | -$2.05M | -$3.54M | -$6.37M | -$31.18M | -$10.55M |
| Net Profit | -$40.76M | -$55.43M | -$43.17M | -$146.41M | -$8.95M |
| Profit from Continuing Operations | -$40.76M | -$55.43M | -$43.17M | -$146.41M | -$8.95M |
| Net Income to Parent Company | -$40.76M | -$55.43M | -$43.17M | -$146.41M | -$8.95M |
| Net Income to Common Stockholders | -$40.76M | -$55.43M | -$43.17M | -$146.41M | -$8.95M |
| Basic EPS | -$0.13 | -$0.18 | -$0.14 | -$0.49 | -$0.03 |
| Diluted EPS | -$0.13 | -$0.18 | -$0.14 | -$0.49 | -$0.03 |
| Non-Operating Interest Expense | – | $42,000.00 | – | – | – |
| Other Income (Expense) | – | – | – | -$2.71M | -$153,000.00 |
| Other Non-Operating Income (Expenses) | – | – | – | -$2.71M | -$153,000.00 |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $1.50B | $1.31B | $1.31B | $1.36B | $1.36B |
| Total Current Assets | $876.16M | $679.23M | $664.60M | $728.23M | $728.23M |
| Cash and Cash Equivalents & Short-Term Investments | $764.42M | $540.10M | $504.73M | $533.83M | $533.83M |
| -Cash and Cash Equivalents | $163.80M | $120.07M | $77.06M | $128.51M | $128.51M |
| -Short Term Investments | $600.62M | $420.04M | $427.67M | $405.31M | $405.31M |
| Receivables | $67.28M | $95.43M | $115.73M | $153.40M | $153.40M |
| -Accounts Receivable | $17.96M | $18.60M | $36.76M | $58.29M | $58.29M |
| -Loans Receivable | $38.29M | $38.42M | $39.16M | $39.41M | $39.41M |
| -Taxes Receivable | $11.02M | $38.41M | $39.80M | $55.70M | $55.70M |
| Inventory | $7.57M | $7.58M | $7.86M | $6.34M | $6.34M |
| Restricted Cash | $25.00M | $25.00M | $25.00M | $25.00M | $25.00M |
| Other Current Assets | $11.89M | $11.12M | $11.28M | $9.67M | $9.67M |
| Total Non-Current Assets | $623.71M | $628.35M | $642.52M | $628.72M | $628.72M |
| Net PPE | $410.05M | $416.68M | $422.81M | $428.00M | $428.00M |
| -Gross PPE | $485.36M | $486.21M | $486.34M | $485.62M | $485.62M |
| -Accumulated Depreciation | -$75.31M | -$69.54M | -$63.53M | -$57.61M | -$57.61M |
| Investments and Advances | $63.85M | $65.23M | $65.31M | $62.58M | $62.58M |
| -Long Term Equity Investment | $63.85M | $65.23M | $65.31M | $62.58M | $62.58M |
| Goodwill and Other Intangible Assets | $86.20M | $84.34M | $85.27M | $86.19M | $86.19M |
| -Goodwill | $47.81M | $47.81M | $47.81M | $47.81M | $47.81M |
| -Other Intangible Assets | $38.39M | $36.53M | $37.46M | $38.38M | $38.38M |
| Other Non-Current Assets | $63.62M | $62.10M | $69.14M | $51.95M | $51.95M |
| Total Liabilities | $437.36M | $411.56M | $369.03M | $390.05M | $390.05M |
| Total Current Liabilities | $70.47M | $53.19M | $47.29M | $64.31M | $64.31M |
| Payables | $13.73M | $12.11M | $20.81M | $25.23M | $25.23M |
| -Accounts Payable | $13.73M | $12.11M | $20.81M | $25.23M | $25.23M |
| Current Accrued Expenses | $7.80M | $6.08M | $3.93M | $10.76M | $10.76M |
| Short-Term Debt and Capital Lease Obligation | $5.69M | $5.67M | $5.87M | $5.82M | $5.82M |
| -Current Capital Lease Obligation | $5.69M | $5.67M | $5.87M | $5.82M | $5.82M |
| Current Deferred Liabilities | $43.25M | $29.34M | $16.69M | $22.51M | $22.51M |
| Total Non-Current Liabilities | $366.89M | $358.37M | $321.74M | $325.74M | $325.74M |
| Long Term Debt and Capital Lease Obligation | $128.13M | $129.95M | $134.31M | $137.40M | $137.40M |
| -Long Term Capital Lease Obligation | $128.13M | $129.95M | $134.31M | $137.40M | $137.40M |
| Non-Current Deferred Liabilities | $228.33M | $218.70M | $176.11M | $183.57M | $183.57M |
| Other Non-Current Liabilities | $10.44M | $9.71M | $11.32M | $4.77M | $4.77M |
| Total Equity | $1.06B | $896.02M | $938.08M | $966.90M | $966.90M |
| Stockholders' Equity | $1.06B | $896.02M | $938.08M | $966.90M | $966.90M |
| Capital Stock | $996.19M | $821.24M | $816.53M | $802.34M | $802.34M |
| -Common Stock | $996.19M | $821.24M | $816.53M | $802.34M | $802.34M |
| Additional Paid-In Capital | $238.57M | $206.00M | $196.62M | $198.28M | $198.28M |
| Retained Earnings | -$168.83M | -$128.07M | -$72.65M | -$29.48M | -$29.48M |
| Gains/Losses Not Affecting Retained Earnings | -$3.42M | -$3.15M | -$2.42M | -$4.23M | -$4.23M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $26.91M | $25.92M | -$33.52M | -$131.30M | -$34.74M |
| Net cash flow from continuing operations | $26.91M | $25.92M | -$33.52M | -$131.30M | -$34.74M |
| Net Income from Continuing Operations | -$40.76M | -$55.43M | -$43.17M | -$146.41M | -$8.95M |
| Depreciation & Depletion & Amortization | $8.62M | $8.78M | $8.66M | $28.82M | $7.92M |
| Other Non-Cash Items | -$1.42M | $4.64M | $2.38M | $1.20M | -$403,000.00 |
| Change in Working Capital | $48.81M | $55.64M | -$13.40M | -$70.69M | -$46.22M |
| -Change in Receivables | $23.20M | $4.24M | $13.10M | -$55.62M | -$19.87M |
| -Change in Payables and Accrued Expense | $3.31M | -$2.25M | -$14.38M | $3.46M | $5.74M |
| -Change in Other Current Assets | $2.62M | $3.58M | -$1.74M | $17.15M | $3.07M |
| -Change In Other Working Capital | $19.67M | $50.07M | -$10.39M | -$35.68M | -$35.16M |
| Net cash flow from investing | -$183.44M | $11.34M | -$25.08M | $87.75M | $75.14M |
| Net Cash Flow from Continuing Investing Activities | -$183.44M | $11.34M | -$25.08M | $87.75M | $75.14M |
| Net PPE Purchase and Sale | -$1.61M | -$2.13M | -$3.83M | -$42.77M | -$9.84M |
| Net Investment Purchase and Sale | -$182.05M | $7.88M | -$22.61M | $52.94M | $14.76M |
| Net Other Investing Changes | $229,000.00 | $5.59M | $1.36M | $54.61M | $47.25M |
| Financing Cash Flow | $200.64M | $6.39M | $7.19M | $14.08M | $4.12M |
| Net Cash Flow from Continuing Financing Activities | $200.64M | $6.39M | $7.19M | $14.08M | $4.12M |
| Net Other Financing Charges | $11.81M | $6.39M | $7.19M | $14.08M | $4.12M |
| Ending Cash Balance | $190.76M | $147.03M | $103.80M | $155.25M | $155.25M |
| Net Change in Cash | $44.11M | $43.66M | -$51.41M | -$29.46M | $44.51M |
| Beginning Cash Balance | $147.03M | $103.80M | $155.25M | $183.62M | $110.45M |
| Effect of Exchange Rate Changes | -$379,000.00 | -$430,000.00 | -$38,000.00 | $1.10M | $290,000.00 |
| Free Cash Flow | $25.30M | $23.79M | -$37.35M | -$174.07M | -$44.59M |
| Net Business Purchase and Sale | – | – | – | -$7.14M | -$251,000.00 |
No comments yet — be the first to weigh in on ABCL.
Sign in to join the discussion.